First human test of experimental cancer combo in japan
NCT ID NCT03972150
Summary
This early-stage study tested two experimental cancer drugs—BI 836880 alone and combined with BI 754091—in 21 Japanese patients with advanced solid tumors. The main goal was to find the highest safe doses for future research, not to treat cancer. Researchers carefully monitored how the drugs moved through the body and what side effects occurred at different dose levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Center Hospital
Tokyo, Chuo-ku, 104-0045, Japan
-
Shizuoka Cancer Center
Shizuoka, Sunto-gun, 411-8777, Japan
Conditions
Explore the condition pages connected to this study.